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Purpose: Curcumin (Cur) has been reported to induce apoptosis in human renal carcino-
ma Caki cells. Dimethoxycurcumin (DMC), one of several synthetic Cur analogues, has 
been reported to have increased metabolic stability over Cur. We determined whether 
DMC, like Cur, induces apoptosis in Caki cells and also compared the apoptosis-induc-
ing activity of DMC with that of Cur.
Materials and Methods: Caki cells were treated with DMC possessing four methoxy 
groups, Cur possessing two methoxy groups, or bis-demethoxycurcumin (BMC), which 
lacks a methoxy group. Cell viability was measured by using a methyltetrazolium 
assay. Flow cytometry and the caspase-3 activity assay were used to detect apoptosis. 
The release of cytochrome-c (Cyt c) was detected by Western blot analysis. The pro-
duction of reactive oxygen species (ROS) was measured by flow cytometry. 
Results: DMC, Cur, and BMC reduced cell viability and induced apoptosis, but the po-
tency varied; DMC was the most potent compound, followed by Cur and BMC. ROS pro-
duction, Cyt c release, and caspase-3 activity were increased, again in the order DMC＞
Cur＞BMC. N-Acetylcysteine, a potent antioxidant, inhibited ROS production, Cyt c 
release, caspase-3 activation, and apoptosis induction in DMC-treated cells.
Conclusions: These results indicate that DMC, like the original form of Cur, may induce 
apoptosis in human renal carcinoma Caki cells through the production of ROS, the re-
lease of mitochondrial Cyt c, and the subsequent activation of caspase-3. In addition, 
DMC is more potent than Cur in the ability to induce apoptosis. 
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INTRODUCTION
In recent years, a rapid increase in the costs of health care 
has facilitated the importance of plant-derived poly-
phenols for the prevention and treatment of human dis-
eases, including cancer. Among the polyphenols, curcumin 
(Cur) has been most extensively investigated for its cancer 
chemopreventive and chemotherapeutic properties [1]. 
Several studies have shown that Cur is a potent inhibitor 
of tumor initiation in vivo [2,3] and possesses anti-pro-
liferative activities against cancer cells in vitro [4,5]. 
Moreover, Cur has been reported to induce apoptosis in di-
verse human cancer cells [6,7]. The mechanism or mecha-
nisms by which Cur can induce apoptosis in cancer cells re-
main poorly understood; however, it is most likely that Cur 
may induce apoptosis, at least in part, through the gen-
eration of reactive oxygen species (ROS), the release of mi-
tochondrial cytochrome c (Cyt c), and the subsequent acti-Korean J Urol 2010;51:870-878
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FIG. 1. Chemical structures of dimethoxycurcumin (DMC), cur-
cumin (Cur), and bis-demethoxycurcumin (BMC). Note that the 
original form of Cur contains two methoxy groups at two aromatic 
rings, whereas DMC contains four, and BMC contains none.
vation of caspase-3 [8-13]. 
　Cur, a member of the naturally occurring curcuminoid 
family, is a yellow-colored phenolic pigment in turmeric; 
the other two curcuminoids being demethoxycurcumin 
and bis-demethoxycurcumin (BMC). Both the inhibition of 
proliferation and the induction of apoptosis are associated 
with the cellular uptake of curcuminoids [14], which may 
be dependent on the number of methoxy groups at their ar-
omatic rings. Cur is rapidly metabolized in vivo into tetra-
hydrocurcumin and other reduced forms in rats and mice 
and in vitro in human hepatic cells [15,16]. It has been dem-
onstrated that some pharmacological activities are lost 
when Cur is reduced to its metabolites [15]. Thus, there is 
a need to develop Cur analogues with a higher metabolic 
stability than Cur. Dimethoxycurcumin (DMC), one of sev-
eral synthetic Cur analogues, has been reported to have in-
creased metabolic stability in comparison with Cur [17]. 
Interestingly, DMC can induce apoptosis in human 
HCT116 colon cancer cells [17], but its apoptosis-inducing 
effect against other cancer cells, such as renal cancer cells, 
has not been investigated. 
　Renal carcinoma remains one of the most drug-resistant 
malignancies in humans and is a frequent cause of cancer 
mortality [18,19]. Interestingly, two studies have demon-
strated that Cur can induce apoptosis in human renal carci-
noma Caki cells [20,21]. This prompted us to determine 
whether DMC would also induce apoptosis in Caki cells. 
For this purpose, we compared the ability of DMC, Cur, and 
BMC to induce apoptosis in terms of the number of methoxy 
groups in their chemical structures and also investigated 
the possible mechanisms by which DMC could induce 
apoptosis. 
MATERIALS AND METHODS
1. Chemicals and antibodies
Cur and BMC were isolated from the rhizomes of turmeric, 
as described earlier [22]. DMC was synthetically prepared, 
as described previously [23], at the College of Pharmacology, 
Wonkwang University (Iksan, Korea). The purity of each 
compound, as detected by HPLC, was ＞90%. All solvents 
used in this study were LC-MS grade and were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). The chemical 
structures of the three compounds examined in this study 
are shown in Fig. 1. Whereas the original form of Cur con-
tains two methoxy groups at two aromatic rings, DMC con-
tains four, and BMC contains none. 3-(4,5-Dimethyl-2- 
thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) and 2', 
7'-dichlorofluorescin diacetate (DCF-DA) were purchased 
from Sigma-Aldrich. Primary antibodies against Cyt c and 
β-actin and secondary antibodies against each antibody 
were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA).
2. Cell culture 
Human renal carcinoma Caki cells were obtained from the 
American Type Culture Collection (ATCC, Rockville, MD, 
USA). The culture medium used throughout these experi-
ments was Dulbecco's modified Eagle's medium (Sigma- 
Aldrich), containing 10% fetal bovine serum (Invitrogen, 
Carlsbad, CA, USA), 20 mM HEPES buffer and antibiotics 
(100 U/ml penicillin G and 100 μg/ml streptomycin). Cul-
tures were maintained at 37
oC in a humidified 5% CO2 
atmosphere. Fresh medium was given every second day 
and on the day before the experiments were done. Com-
pounds used in this study were dissolved in dimethyl sulf-
oxide (DMSO), and all cells received DMSO to a final con-
centration of 2% (v/v). Controls were always treated with 
the same amount of DMSO.
3. Cell viability assay
Cell viability was determined by a modified MTT reduction 
assay. MTT is a pale yellow substance that is reduced by 
living cells to yield a dark blue formazan product. This proc-
ess requires active mitochondria, and even fresh dead cells 
do not reduce significant amounts of MTT. Caki cells were 
cultured in a 96-well flat-bottom plate at a concentration 
of 5x10
5 cells/ml. After 12 h of preconditioning, the cells 
were treated with various concentrations of DMC or other 
agents for 24 h. Thereafter, the culture medium was aspi-
rated and 100 μl of MTT dye (1 mg/ml in phosphate-buf-
fered saline [PBS]) was added; the cultures were incubated 
for 4 h at 37
oC. The formazan crystals produced through 
dye reduction by viable cells were dissolved by using acidi-
fied isopropanol (0.1 N HCl). An index of cell viability was 
calculated by measuring the optical density of the color pro-
duced by MTT dye reduction at 570 nm.Korean J Urol 2010;51:870-878
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FIG. 2. Effects of dimethoxycurcumin (DMC), curcumin (Cur), and bis-demethoxycurcumin (BMC) on viability and DNA fragmentation
of Caki cells. (A) Cells were treated for 24 h with the indicated concentrations of DMC. (B) Cells were treated with 80 μM of DMC for
the indicated times. (C) Cells were treated for 24 h with 80 μM of DMC, Cur, or BMC. Cell viability was analyzed by use of the MTT
assay. Each bar represents the Mean±SD (n=4). 
a: p＜0.05 compared with the control groups, 
b: p＜0.05 compared with the DMC-treated
groups. (D) Cells were treated for 12 h with 10 μM of H2O2 (served as a positive control) or for 24 h with 80 μM of DMC, Cur, or BMC,
and DNA fragmentation was analyzed by agarose gel electrophoresis. This experiment was repeated three times with similar results.
4. DNA fragmentation assay
Caki cells were harvested, washed with PBS, and then 
lysed overnight at 56
oC with a digestion buffer containing 
0.5% sarkosyl, 0.5 mg/ml proteinase K, 50 mM tris(hydrox-
ymethyl) aminomethane (pH 8.0), and 10 mM EDTA. 
Following lysis, the cells were then treated with RNase A 
(0.5 μg/ml) for 3 h at 56
oC. The DNA was then extracted by 
using phenol/chloroform/isoamyl alcohol (25:24:1) before 
loading and was analyzed by 2% agarose gel electrophore-
sis. The agarose gels were run at 50 V for 120 minutes in 
Tris-borate/EDTA electrophoresis buffer. Approximately 
20 μg of DNA was loaded in each well with 6x loading buffer 
containing 0.25% bromophenol blue, 0.25% xylene xyanol, 
and 40% sucrose. DNA was stained with ethidium bromide 
and visualized under UV light (wavelength, 260 nm), and 
the plates were photographed.
5. Measurement of apoptosis
Apoptosis was examined by using an FITC-labeled Annexin 
V/propidium iodide (PI) apoptosis detection kit (Sigma- 
Aldrich) according to the manufacturer’s instructions. 
Briefly, 1x10
6 Caki cells were harvested and washed with 
PBS. The cells were resuspended in 400 μl of binding buffer. 
Next, 5 μl of Annexin V-FITC and 1 μl of PI were added. Flow 
cytometric analysis was performed immediately after 
staining. Data acquisition and analysis were performed by 
a fluorescence-activated cell scanner (FACScan) flow cy-
tometer (Becton Dickinson, San Jose, CA, USA). Cells in 
the early stages of apoptosis were Annexin V positive and 
PI negative, whereas cells in the late stages of apoptosis 
were both annexin V and PI positive.
6. Measurement of ROS production
Changes in intracellular ROS levels were evaluated by 
measuring the oxidative conversion of DCFH-DA to fluo-Korean J Urol 2010;51:870-878
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FIG. 3. Effects of dimethoxycurcumin (DMC), curcumin (Cur), and bis-demethoxycurcumin (BMC) on apoptosis in Caki cells. (A) Cells
were treated for 12 h with solvent (control) or with 80 μM of DMC and were then stained by Annexin V-FITC/PI solution and analyzed
by flow cytometry (cells in the lower right quadrant represent apoptosis). Cells were treated for 12 h with the indicated concentrations
of DMC (B) or with 80 μM of DMC, Cur, or BMC (C). After Annexin V/PI staining, flow cytometric analysis was performed to determine
the percentage of Annexin-V positive cells. Each bar represents the Mean±SD (n=4). 
a: p＜0.05 compared with the control groups, 
b: 
p＜0.05 compared with the DMC-treated groups.
rescent DCF. Caki cells grown in 12-well plates were loaded 
with 10 μM of DCFH-DA for 30 min at 37
oC and were then 
incubated with Cur analogues under the indicated condi-
tions. The cells were washed with PBS and harvested by 
gentle scraping. DCF fluorescence in 10,000 cells was de-
tected by a FACScan flow cytometer. The results were ob-
tained as histogram plots of cell number to fluorescence in-
tensity, and the mean fluorescence for each sample within 
an experiment was analyzed by using CellQuest Software 
(Becton Dickinson). 
7. Western blot analysis
Cells were lysed in lysis buffer (20 mM Tris-HCl, 150 mM 
NaCl, 2 mM EDTA, 1% Triton-X 100) containing a protease 
inhibitor cocktail (Sigma-Aldrich). Cell extract protein 
amounts were quantified by using the BCA protein assay 
kit (Sigma-Aldrich). Protein lysates (50 μg per lane) were 
resolved on sodium dodecyl sulfate 10% to 14% polyacry-
lamide gels and transferred to nitrocellulose membranes; 
the membranes were then incubated with mouse poly-
clonal antibody against Cyt c. Peroxidase-conjugated goat 
anti-mouse antibody was used as secondary antibodies. 
Immune complexes were visualized with the use of an ECL 
solution (Amersham Biosciences, UK) according to the 
manufacturer’s instructions. 
8. Measurement of caspase-3 activity
Caki cells treated with compounds were collected and 
washed with PBS and suspended in 25 mM HEPES (pH 
7.5), 5 mM MgCl2, 5 mM EDTA, 5 mM dithiothione, 2 mM 
phenylmethanesulfonyl fluoride, 10 μg/ml pepstatin A, 
and 10 μg/ml leupeptin. Cell lysates were clarified by cen-
trifugation at 12,000 g for 20 min at 4
oC. Caspase activity 
in the supernatant was determined by a fluorogenic assay 
(Promega's CaspACE Assay System Corp., Madison, WI, 
USA). Briefly, 50 μg of total protein, as determined by BCA Korean J Urol 2010;51:870-878
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FIG. 4. Effects of dimethoxycurcumin (DMC), curcumin (Cur), and bis-demethoxycurcumin (BMC) on reactive oxygen species (ROS)
production in Caki cells. (A) Cells stained by DCF-DA were treated for 6 h with solvent (control) or with 80 μM of DMC and were then
analyzed by flow cytometry. Data are presented as log fluorescence intensity. Cells stained by DCF-DA were treated for 6 h with the 
indicated concentrations of DMC (B) or with 80 μM of DMC, Cur, or BMC (C). Flow cytometric analysis was performed to determine 
the mean fluorescence intensity of DCF-positive cells. Each bar represents the mean±SD (n=4). 
a: p＜0.05 compared with the control
groups, 
b: p＜0.05 compared with the DMC-treated groups.
protein assay kit (Sigma-Aldrich), was incubated with 50 
μM of caspase-3-specific substrate (Ac-DEVD-AMC) at 
30
oC for 1 h. The release of methylcoumaryl-7-amine 
(AMC) was measured by excitation at 360 and emission at 
460 nm with a fluorescence spectrophotometer.
9. Statistical analysis 
The results were expressed as Means±SD. Statistical sig-
nificance was estimated by Student’s t-test for unpaired ob-
servations between two groups or by ANOVA with Bonfer-
roni correction for comparisons of multiple groups. At least 
three independent experiments were carried out for each 
variable. The level of significance was accepted at p＜0.05. 
RESULTS
1. DMC reduces cell viability by apoptosis in Caki renal car-
cinoma cells
Human renal carcinoma Caki cells were exposed to increas-
ing concentrations of DMC for 24 h. A notable loss of cell 
viability (approximately 40%) was observed after treat-
ment with 80 μM of DMC (Fig. 2A). A significant reduction 
of cell viability was first observed after 6-h treatment with 
80 μM of DMC and was found to be maximal after 24-h treat-
ment (Fig. 2B). At 80 μM, Cur and BMC, like DMC, also re-
duced cell viability, but the potency varied; DMC was the 
most potent compound, followed by Cur and BMC (Fig. 2C). 
A typical ladder pattern of DNA fragmentation, which is 
considered a hallmark of apoptotic cell death, was observed 
when Caki cells were treated for 24 h with 80 μM of DMC, 
Cur, or BMC (Fig. 2D), which indicated that the loss of cell 
viability by these agents was due to the induction of 
apoptosis. 
　The quantitative measurement of apoptosis by use of the 
Annexin V/PI staining assay showed the percentage of can-
cer cells that underwent apoptosis after 12-h treatment 
with different concentrations of DMC (Fig. 3A, B). The in-
duction of apoptosis was first observed after 6-h treatment Korean J Urol 2010;51:870-878
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FIG. 5. Effects of dimethoxycurcumin (DMC), curcumin (Cur), and bis-demethoxycurcumin (BMC) on cytochrome c (Cyt c) release and
caspase-3 activity in Caki cells. Cells were treated for 6 h with the indicated concentration of DMC (A) or with 80 μM of DMC, Cur,
or BMC (B). Subcellular fractions were prepared and cytosolic Cyt c was detected by Western blot analysis with Cyt c antibody. These
experiments were repeated three times with similar results. Cells were treated for 12 h with the indicated concentrations of DMC (C)
or with 80 μM of DMC, Cur, or BMC (D). Caspase-3 activity was analyzed by a fluorogenic assay, as described in the Materials and
Methods. Each bar represents the mean±SD (n=4). 
a: p＜0.05 compared with the control groups, 
b: p＜0.05 compared with the DMC-t
reated groups.
with 80 μM of DMC and gradually increased until 24 h (not 
shown). A comparable increase in apoptotic cells was also 
observed when Caki cells were exposed for 12 h to 80 μM 
of Cur or BMC (Fig. 3C). Again, DMC was the most effective 
in inducing apoptosis, followed by Cur and BMC (Fig. 3C). 
These data are in agreement with the ability of these com-
pounds to reduce cell viability (Fig. 2D), which suggests the 
important role of the methoxy groups in DMC in the in-
duction of apoptosis. 
2. DMC induces ROS production, Cyt c release, and cas-
pase-3 activation
The level of ROS production in cellular systems was inves-
tigated by using the specific fluorescent dye DCF-DA. This 
probe detects intracellular ROS and fluoresces after form-
ing DCF inside cells. Therefore, an increase in fluorescence 
indicates increased production of cellular ROS. Fig. 4A and 
B show overlapped histograms of flow cytometric fluo-
rescence intensity patterns of ROS produced by Caki cells 
after treatment with 80 μM of DMC for 6 h and a dose de-
pendency between the concentration of DMC and ROS pro-
duction, respectively. ROS production was found to be max-
imal after 6-h treatment with DMC, but at near basal levels 
after 24-h treatment (not shown). At 80 μM, Cur and BMC, 
like DMC, also induced significant levels of ROS, but they 
differed in their ability to induce ROS production (Fig. 4C). 
DMC was the most potent compound, followed by Cur and 
BMC. These results correlate well with the data on in-
duction of apoptosis. 
　Cyt c is a component of the mitochondrial electron trans-
port chain and is present in the inner membrane space. 
Disruption of the outer mitochondrial membrane by apop-
totic stimuli, including H2O2, results in the release of Cyt 
c into the cytoplasm, which activates a cascade of caspases 
involved in apoptosis. Western blotting analysis with cyto-
solic fractions was carried out to examine the release of Cyt 
c from mitochondria in DMC-treated Caki cells. Cytosolic 
localization of Cyt c was clearly observed in Caki cells treat-
ed for 6 h with 40 μM or 80 μM of DMC (Fig. 5A). When exam-
ined at a given concentration (80 μM), DMC was the most Korean J Urol 2010;51:870-878
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FIG. 6. Effects of N-acetylsysteine (NAC) on reactive oxygen species (ROS) production, cytochrome c (Cyt c) release, caspase-3 
activation, and apoptosis induction in dimerthoxycurcumin (DMC)-treated Caki cells. Cells were pre-incubated for 1 h with 10 mM 
of NAC and were then exposed for either 6 h (A, B) or 12 h (C, D) to 80 μM of DMC. ROS production (A) and apoptosis induction (D)
were determined by flow cytometric analysis using DCF-DA and Anennxin V plus PI, respectively. Cytosolic Cyt c (B) was detected
by Western blot analysis using Cyt c antibody. Caspase-3 activity (C) was analyzed by a fluorogenic assay. Each bar represents the 
Mean±SD (n=4). 
a: p＜0.05 compared with the control groups, 
b: p＜0.05 compared with the groups treated with DMC alone.
effective in inducing the release of Cyt c, followed by Cur 
and BMC (Fig. 5B). These results correlate well with the 
data on ROS production. 
　Activation of caspases by Cyt c is a key event during apop-
tosis caused by various anticancer drugs. Caspase-3 activ-
ity was significantly increased when Caki cells were ex-
posed for 12 h to 40 μM or 80 μM of DMC (Fig. 5C). At 80 
μM of DMC, an increase in caspase-3 activity was first ob-
served after 6-h treatment with DMC, and activity gradu-
ally increased until 24 h (not shown). In comparison, the 
caspase-3 activity was increased in the order DMC ＞  Cur 
＞  BMC (Fig. 5D). These results correlate well with the data 
on Cyt c release.
3. ROS production is involved in apoptosis by DMC
Numerous chemical and physical treatments capable of in-
ducing apoptosis can also induce ROS production [24], sug-
gesting a close relationship between ROS production and 
apoptosis. To determine whether ROS production could be 
responsible for the induction of apoptosis by DMC, Caki 
cells were treated with 80 μM of DMC in the presence or 
absence of the antioxidant N-acetylsysteine (NAC), and 
were analyzed for ROS production, Cyt c release, caspase-3 
activation, and apoptosis. As shown in Fig. 6, NAC pretreat-
ment inhibited ROS production, Cyt c release, caspase-3 
activation, and apoptosis induction in DMC-treated cells. 
Pretreatment of Caki cells with either 10,000 units of cata-
lase or 50 μM of vitamin E also inhibited the induction of 
apoptosis by DMC (not shown).
DISCUSSION
Cur is the major component of the root of the plant Curcuma 
longa. A wealth of data indicates that this compound has 
potent antitumor effects against a variety of cancer cell 
lines in vitro and chemopreventive effects in carcinoma an-Korean J Urol 2010;51:870-878
Apoptosis Induction by Dimethoxycurcumin 877
imal models [1-7]. Moreover, phase I clinical trials have 
shown that Cur is safe even at high doses (12 g/d) in humans 
[25]. However, Cur exhibits poor bioavailability due to poor 
absorption, rapid metabolism, and rapid systemic elimi-
nation [26]. To improve the bioavailability of Cur, several 
approaches are being analyzed: these may include agents 
that block the metabolic pathway of Cur, phospholipid com-
plexes to provide better permeability and longer circu-
lation, and structural analogues of Cur that provide sev-
eral fold higher bioavailability than that of Cur [1]. In this 
study, we determined whether DMC, a structural analogue 
of Cur with higher metabolic stability over the original Cur, 
would induce apoptosis to a similar extent in human renal 
carcinoma Caki cells. The data presented here demon-
strate that DMC is more potent than Cur in its ability to 
induce apoptosis. 
　ROS may play a crucial role in cell growth and apoptosis 
in cancer cells. An appropriate level of intracellular ROS 
promotes cellular proliferation [27], whereas excessive 
production of ROS leads to oxidative stress, loss of cell func-
tion, and ultimately apoptosis [24,27]. ROS production 
leads to the depolarization of the mitochondrial membrane 
and releases pro-apoptotic molecules from mitochondria 
into the cytosol, which may act to induce apoptosis [28]. The 
release of the pro-apoptotic molecule Cyt c from the mi-
tochondrial membrane results in an increased level of Cyt 
c in the cytoplasm and nucleus, which may activate cas-
pase-9, which, in turn, triggers the effector caspase-3 [28]. 
In this regard, a number of recent studies have suggested 
the possibility of using agents that promote cellular ROS 
accumulation to effectively kill cancer cells in vitro [28]. 
　Cur, like most polyphenols, has been reported to induce 
ROS production when exposed to cancer cells [8-12]. 
Moreover, two studies have demonstrated that Cur can in-
duce apoptosis through ROS production in human renal 
carcinoma Caki cells [20,21]. In light of the structural sim-
ilarity between Cur and DMC, DMC can be recognized to 
have a chemical property resembling that of Cur. Indeed, 
induction of apoptosis by DMC in Caki cells was accom-
panied by an increase in the intracellular ROS level, the 
release of mitochondrial Cyt c into the cytosol, and the acti-
vation of caspase-3. NAC, an antioxidant agent, blocked the 
DMC-induced ROS production, blocked Cyt c release, and 
rescued cells from DMC-induced apoptosis. These results 
indicate that DMC, like Cur, induces apoptosis in Caki cells 
through a ROS-dependent signaling pathway, and this 
raises the question of how the three Cur analogues (i.e., 
DMC, Cur, and BMC) vary in their ability to induce apopto-
sis in renal carcinoma cells. DMC contains four methoxy 
groups, Cur contains two, and BMC contains none (Fig. 1). 
Our finding that DMC is maximally active, Cur is inter-
mediate, and BMC is least active suggests that the methoxy 
groups do contribute to the enhancement of apoptosis. How 
the methoxy groups enhance apoptotic activity, however, 
is currently unclear. Recently, Tamvakopoulos et al showed 
that in comparison with Cur, the metabolism of DMC is less 
extensive in a cellular system [17]. Thus, it is possible that 
the differential efficiency of the Cur analogues may be asso-
ciated with their different metabolic stabilities. Also, the 
differential efficiency of the Cur analogues may be caused 
by a different permeability of the compounds across the cell 
membrane, probably due to the number of hydrophobic me-
thoxy groups. Hsu and Cheng previously showed that in-
creased apoptosis in colon cancer cells appears to be asso-
ciated with the cellular uptake of Cur analogues [25]. 
　Accumulating evidence suggests that the mode of 
Cur-induced cell death is mediated both by the activation 
of cell death pathways and by the inhibition of cell survival 
pathways. The role of mitochondria, among others, is well 
established in the induction of cell death by Cur [29], imply-
ing that the mitochondrial pathway might be the major 
pathway mediating the Cur-induced cell death. As evi-
denced by numerous studies, Cur-induced ROS formation 
causes the release of Cyt c from the mitochondria to the cy-
tosol, hence leading to activation of caspase-9 and caspase- 
3 [29]. Additionally, Cur has been shown to inhibit the ex-
pression of anti-apoptotic proteins, including Bcl-2, Bcl- 
xL, and inhibitors of apoptosis (IAP) [29]. Indeed, Cur causes 
apoptosis of Caki cells, which is preceded by the sequential 
dephosphorylation of Akt, the down-regulation of the an-
ti-apoptotic proteins (e.g., Bcl-2, Bcl-xL, and IAP), the for-
mation of ROS, the release of Cyt c, and the activation of 
caspase-3 [20]. In our study, we have shown that DMC can 
induce apoptosis of Caki cells by the formation of ROS, the 
release of Cyt c, and the activation of caspase-3; however, 
other pathways could also be involved in DMC-induced cell 
death. Further studies are needed to investigate whether 
DMC, like the original form Cur, would down-regulate the 
expression of the anti-apoptotic proteins in Caki cells.
CONCLUSIONS 
Our results have provided experimental evidence support-
ing that DMC, like the original form Cur, can induce apop-
tosis in Caki cells through the production of ROS, the re-
lease of mitochondrial Cyt c, and the subsequent activation 
of caspase-3. DMC, however, is more potent than Cur in its 
ability to induce apoptosis. Similar to Cur, DMC also seems 
to have multiple molecular targets, and its enhanced po-
tency in cancer cell lines renders it a strong candidate for 
therapeutic applications for renal cancer as well as other 
cancers.
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